Children with primary immunodeficiency (PID) are at a higher risk of developing serious complications from COVID-19, according to a new study.
PID is a group of more than 400 disorders that occur when the body’s immune system is not working properly.
The study, published in the journal Frontiers in Pediatrics, examined data from 41 children with PID who were diagnosed with COVID-19.
Of the 41 children, 19 (46%) were hospitalized and four (10%) required intensive care.
One child died from the virus.
The study found that children with PID who required hospitalization were more likely to have respiratory failure, need mechanical ventilation, and have longer hospital stays.
“Our study highlights the importance of early recognition and management of COVID-19 in children with PID,” said study lead author Dr. Christina Cuda, of the University of Miami Miller School of Medicine.
“Children with PID are at increased risk for severe COVID-19 and should be closely monitored for signs and symptoms suggestive of COVID-19.”
The study also found that children with PID who were not hospitalized still had a higher risk of developing complications from COVID-19.
Of the 22 children who were not hospitalized, seven (32%) required oxygen, and three (14%) had fever for more than 10 days.
“This study underscores the importance of early recognition and aggressive management of COVID-19 in children with PID,” said study senior author Dr. Scott D. Cooper, also of the University of Miami Miller School of Medicine.
“PID is a rare but serious condition, and our findings suggest that children with PID are at increased risk for severe COVID-19.”
The findings highlight the need for increased awareness of the increased risk of serious COVID-19 complications in children with PID.
A new study has found that children with primary immunodeficiency are at a higher risk of developing serious complications from COVID-19, the disease caused by the new coronavirus.
The study, published in the journal Frontiers in Pediatrics, looked at data from 68 children with primary immunodeficiency who were diagnosed with COVID-19. The researchers found that 22% of these children required hospitalization, and 5% were admitted to the intensive care unit.
In contrast, only 3% of children who do not have primary immunodeficiency were hospitalized, and less than 1% were admitted to the ICU.
The findings suggest that children with primary immunodeficiency are at a higher risk of developing severe COVID-19, and that they may require more aggressive treatment.
Primary immunodeficiency is a rare condition that affects the body’s ability to fight infections. It is estimated to affect one in every 1,200 to 2,000 children worldwide.
If your child has primary immunodeficiency, it is important to talk to their doctor about the best ways to protect them from COVID-19.